📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. (2016)

First Author: Swadling L

Attributed to: Immunity in the face of diversity and the development of novel potent HCV vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/vaccines4030027

PubMed Identifier: 27490575

Publication URI: http://europepmc.org/abstract/MED/27490575

Type: Journal Article/Review

Volume: 4

Parent Publication: Vaccines

Issue: 3

ISSN: 2076-393X